Levels of a fusion product of the SLC45A3 and ELK4 genes correlated with prostate cancer disease progression. The fusion product controlled proliferation of prostate cancer cell lines. An unusual pathway and not chromosomal rearrangement led to fusion product expression. PHILADELPHIA — Researchers have identified a potential new pathway in prostate cancer cells by which cancer-driving [...]
Read the complete post at http://aacrnews.wordpress.com/2012/06/19/abnormal-gene-product-associated-with-prostate-cancer-generated-by-unusual-mechanism/
Posted
Jun 19 2012, 10:00 AM
by
AACR News
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Discovery, Stand Up To Cancer, SU2C, prostate cancer, gene fusion, Innovative Research Grant, cis-SAGe, Dr. Hui Li